Stock-based Compensation (Tables)

The following table summarizes stock option activity as of January 30, 2022:


	Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life	Aggregate Intrinsic Value
	(Options in thousands)			(In years)	(Millions)
Outstanding at August 1, 2021	1,372	$	45.61
Granted	—	$	—
Exercised	(32)	$	36.60
Terminated	—	$	—
Outstanding at January 30, 2022	1,340	$	45.83	5.4	$	4
Exercisable at January 30, 2022	1,340	$	45.83	5.4	$	4

The following table summarizes time-lapse restricted stock units, EPS performance restricted stock units and FCF performance restricted stock units as of January 30, 2022:


	Units	Weighted-Average Grant-Date Fair Value
	(Restricted stock units in thousands)
Nonvested at August 1, 2021	1,814	$	45.63
Granted	1,451	$	41.79
Vested	(1,149)	$	43.92
Forfeited	(117)	$	45.08
Nonvested at January 30, 2022	1,999	$	43.86

The following table summarizes TSR performance restricted stock units as of January 30, 2022:


	Units	Weighted-Average Grant-Date Fair Value
	(Restricted stock units in thousands)
Nonvested at August 1, 2021	1,222	$	53.60
Granted	331	$	45.54
Vested	(178)	$	31.35
Forfeited	(147)	$	45.94
Nonvested at January 30, 2022	1,228	$	55.56

Weighted-average assumptions used in the Monte Carlo simulation were as follows:


	2022	2021
Risk-free interest rate	0.46%	0.15%
Expected dividend yield	3.50%	2.85%
Expected volatility	27.42%	29.99%
Expected term	3 years	3 years